CliffBio
small molecule

SERTRALINE HYDROCHLORIDE

SERTRALINE HYDROCHLORIDE

Loss of exclusivity—loss of exclusivity
CompanyNovitium Pharma →See this company's full patent-cliff portfolio

Drug detail

Brand nameSERTRALINE HYDROCHLORIDE
Active ingredientSERTRALINE HYDROCHLORIDE
StrengthEQ 200MG BASE
Dosage formCAPSULE
RouteORAL
ModalitySmall molecule
FDA approvalJanuary 2026
Marketing statusRX

More from Novitium Pharma

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.